Seven Research Studies Funded by American Brain Tumor Association to be Presented at Society for Neuro-Oncology Annual Meeting

CHICAGO, Nov. 18, 2015 /PRNewswire-USNewswire/ -- The American Brain Tumor Association (ABTA) supported seven research studies that were accepted for presentation at the Society for Neuro-Oncology (SNO) annual scientific meeting November 19-22 in San Antonio, Texas.

"We are proud to fund a diverse collection of research that holds great potential to influence the future of neuro-oncology," said Nicole Willmarth, Ph.D., chief science officer, American Brain Tumor Association. "Acceptance at this premier meeting is a testament to their outstanding work and highlights the ABTA's commitment to funding research that strives to improve the lives of those diagnosed with a brain tumor."

The following ABTA-supported studies will be presented:

Priscilla Brastianos, MD, Broad Institute of Harvard and MIT
Genomic characterization of brain metastases reveals novel therapeutic targets
Friday, November 20, 7:00 – 8:30 am

Andrew Venteicher, MD, PhD, Massachusetts General Hospital
Large-scale single-cell RNA-seq reveals a developmental cellular hierarchy in human oligodendroglioma 
Friday, November 20, 10:30 am - 12:00 pm

Betty Y.S. Kim, MD, PhD, Mayo Clinic
Micronenvironmental modulation improves nanomedicine delivery into brain tumors 
Friday, November 20, 7:45 pm

Martyn Sharpe, PhD, Houston Methodist
Novel mitochondrial based chemotherapy using glioma specific mitochondrial targeted drugs 
Friday, November 20, 7:30 - 9:30 pm

Braden C. McFarland, PhD, University of Alabama at Birmingham
Loss of SOCS3 in myeloid cells promotes a decreased M2 macrophage phenotype and an increased cytotoxic T-cell response in a syngeneic model of glioma 
Saturday, November 21, 3:30 - 5:00 pm

Derek Wainwright, PhD, Northwestern University
IDO1 does not function as a tryptophan catabolic enzyme in malignant glioma 
Saturday, November 21, 5:00 - 7:00 pm

Nickpreet Singh, University of Pennsylvania
Using a multi-compartment diffusion model to characterize edema differences between GBMs and brain metastases 
Saturday, November 21, 5:00 - 7:00 pm

Since 1976, the ABTA has funded more than $27 million in research to attract new generations of researchers to the field, support the development of innovative ideas across a broad range of disciplines, and foster collaborative research to improve the lives of people living with a brain tumor.  To learn more about research currently funded by the ABTA, go to http://www.abta.org/brain-tumor-research/currently-funded-research.html

ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION
Founded in 1973, the American Brain Tumor Association was the first and is now the only national organization committed to funding brain tumor research and providing education and information on all tumor types and for all age groups. For more information, visit www.abta.org or call 800-886-ABTA (2282).

CONTACT:
Julie Landmesser
219-201-4228
[email protected]

Logo - http://photos.prnewswire.com/prnh/20150901/262855LOGO

SOURCE American Brain Tumor Association

Related Links

http://www.abta.org/